Condition
Embryonal Tumor With Multilayered Rosettes
Total Trials
6
Recruiting
5
Active
5
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Early P 1 (1)
P 1 (3)
P 2 (1)
Trial Status
Recruiting5
Not Yet Recruiting1
Clinical Trials (6)
Showing 6 of 6 trials
NCT06861244Phase 2RecruitingPrimary
Embryonal Tumor With Multilayered Rosettes
NCT06465199Phase 1Recruiting
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
NCT06193759Phase 1Recruiting
Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
NCT06942039Early Phase 1Recruiting
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
NCT07390539Phase 1Not Yet Recruiting
B7-H3.CD28Z.CART in CNS Neoplasms
NCT04794686RecruitingPrimary
ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes
Showing all 6 trials